Monoamine oxidase enzymes and oxidative stress in the rat optic nerve: Age-related changes

International Journal of Experimental Pathology

Volumn 93, Issue 6, 2012, Pages 401-405

  Nebbioso, Marcella ^a   Pascarella, Antonia ^a   Cavallotti, Carlo ^a   Pescosolido, Nicola ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Age related change; Deprenyl; Glyceraldehyde 3 phosphate dehydrogenase; Monoamine oxidase; Optic nerve; Oxidative stress

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); MONOAMINE OXIDASE B INHIBITOR;

ADOLESCENT; AGED; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; HISTOCHEMISTRY; IMAGE ANALYSIS; MALE; NERVE FIBER; NEUROPROTECTION; NONHUMAN; OPTIC NERVE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT;

AGE FACTORS; AGING; ANIMALS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MONOAMINE OXIDASE; NERVE FIBERS; OPTIC NERVE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84869079924     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2012.00832.x     Document Type: Article

References (27)

1. Beisenherz G. (1995) Methods in Enzymology (eds. S.P. Colowick & N.O. Kaplan ), New York: Academic Press, pp. 287
2. Berry M. (2004) Glyceraldehyde-3-phosphate dehydrogenase as a target for small-molecule disease-modifying therapies in human neurodegenerative disorders. J. Psychiatry Neurosci. 29, 337-345.
3. Blaschko H. (1974) The natural history of amine oxidase. Rev. Physiol. Biochem. Pharmacol. 70, 83-148.
4. Brus R. (1975) Activity of some enzymes which synthesize and metabolise catecholamines in the brain and peripheral organs in developing rats. Arch. Immunol. Ther. Exp. 23, 449-457.
5. Cao Danh H., Strolin Benedetti M., Dostert P., Mousset A. (1984) Age-related changes in benzylamine oxidase activity in rat tissues. J. Pharm. Pharmacol. 36, 592-596.
6. Carlile G.W., Chalmers-Redman R.M., Tatton N.A., Pong A., Borden K.E., Tatton W.G. (2000) Reduced apoptosis after nerve growth factor and serum withdrawal: conversion of tetrameric glyceraldehyde-3-phosphate dehydrogenase to a dimer. Mol. Pharmacol. 57, 2-12.
7. Fowler C.J., Wiberg A., Oreland L., Marcusson J., Winblad B. (1980) The effect of age on the activity and molecular properties of human brain monoamineoxidase. J. Neural. Transm. 49, 1-20.
8. Hoffman A., Ott A., Breteler M.M. et al. (1997) Atherosclerosis, apolipoprotein and prevalence of dementia and Alzheimer disease in the Rotterdam study. Lancet 349, 151-154.
9. Johnston J.P. (1968) Some observation upon a new inhibitor of monoamine oxidase in brain tissue. Biochem. Pharmacol. 17, 1285-1297.
10. Knoll J. & Magyar K.(1972) Some puzzling pharmacological effects of monoamine oxidase inhibitors. Adv. Biochem. Psychopharmacol. 5:393-408
11. Kusner L.L., Sarthy V.P., Mohr S. (2004) Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase: a role in high glucose-induced apoptosis in retinal Muller cells. Invest. Ophthalmol. Vis. Sci. 45, 1553-1561.
12. Ledoux M. & Lamy F. (1986) Determination of proteins and sulfobetaine with the folin-phenol reagent. Anal. Biochem. 157, 28-31.
13. Mazzola J.L. & Sirover M.A. (2005) Ageing of human glyceraldehyde-3-phosphate dehydrogenase is dependent on its subcellular localization. Biochim. Biophys. Acta 1722, 168-174.
14. Microsystems imaging Solutions (1997) Quantimet 500 Leica. Handbook of Methods. Cambridge, UK: Microsystems imaging Solutions.
15. Moody D.M., Brown W.R., Challa V.R., Ghazi-Birry H.S., Reboussin D.M. (1997) Cerebral microvascular alterations in ageing, leukariosis and Alzheimer's disease. Ann. N. Y. Acad. Sci. 826, 103-116.
16. Owen F., Crow T.J., Frith C.D. et al. (1987) Selective decreases in MAO-B activity in post-mortem brains from schizophrenic patients with type II syndrome. Br. J. Psychiatry 151, 514-519.
17. Rosenstiel P., Sievers J., Lucius R. (2002) Deprenyl fails to promote axonal regeneration of retinal ganglion cells in vitro and in vivo. Cell Tissue Res. 308, 167-175.
18. Saura J., Luque J.M., Cesura A.M. et al. (1994a) Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme autoradiography. Neuroscience 62, 15-30.
19. Saura J., Richards J.G., Maly N. (1994b) Differential age-related changes of MAO-A and MAO-B in mouse brain and peripheral organs. Neurobiol. Aging 15, 399-408.
20. Serio A. (1986) Appunti delle lezioni di Statistica Sanitaria. Roma: Edizioni Kappa.
21. Slater T.F. (1984) Free-radical mechanisms in tissue injury. Biochem. J. 222:1-15
22. Studer A., Baumgartner H.R., Rever K. (1964) Histochemical evidence of monoamine oxidase activity in rats of different ages. Histochemie 79, 43-47.
23. Tatton W.G., Chalmers-Redman R.M., Elstner M. et al. (2000) Glyceraldehyde-3-phosphate dehydrogenase in neurodegeneration and apoptosis signaling. J. Neural Transm. Suppl. 60, 77-100.
24. Tatton W., Chalmers-Redman R., Tatton N. (2003) Neuroprotection by deprenyl and other propargylamines: glyceraldehyde-3-phosphate dehydrogenase rather than monoamine oxidase B. J. Neural. Transm. 110, 509-515.
25. Thomas T. (2000) Monoamine oxidase-B inhibitors in the treatment of Alzheimer's disease. Neurobiol. Aging 21, 343-348.
26. Thomas T., McLendon C., Thomas G. (1999) L-Deprenyl protects vascular endothelium from amyloid-β toxicity and stimulates production of nitric oxide. In: Alzheimer Disease and Related Disorders, pp. 493-500 (Igual K, Swaab D.F ., Winblad B, Wisniewski H. M ), Chischestr: J Wiley & Sons Ltd.
27. Uchida E. & Koelle G.B. (1984) Histochemical investigation of criteria for the distinction between monoamine oxidase A and B in various species. J. Histochem. Cytochem. 32, 667-673.